Obesity, GLP-1s, and the Evidence: What the Data Tells Us

Obesity, GLP-1s, and the Evidence: What the Data Tells Us

In this second episode of our obesity series, preventive cardiologist Neha Pagidipati sheds light on the discovery, impact, and uses of GLP-1s, like Ozempic and Mounjaro. Learn about the impact these medications are having on diabetes, heart disease, and weight management. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-4-obesity-glp-1s-and-evidence-what-data-tells-us

Jaksot(44)

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
tiedekulma-podcast
docemilia
rss-duodecim-lehti
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-tervetuloa-tervemenoa
rss-ylistys-elaimille
rss-tervetta-skeptisyytta